Pregled bibliografske jedinice broj: 941042
Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady state disposition of lamotrigine in adults with epilepsy
Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady state disposition of lamotrigine in adults with epilepsy // British journal of clinical pharmacology, 2018 (2018), PMID: 29791014, 30 doi:10.1111/bcp.13646 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 941042 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Interaction between ABCG2 421C>A polymorphism and
valproate in their effects on steady state
disposition of lamotrigine in adults with epilepsy
Autori
Domjanović, Iva Klarica ; Lovrić Mila ; Trkulja Vladimir ; Petelin Gadže, Željka ; Ganoci Lana ; Čajić Ivana ; Božina Nada
Izvornik
British journal of clinical pharmacology (0306-5251) 2018
(2018);
PMID: 29791014, 30
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
ABCG2 polymorphism ; lamotrigine - valproate interaction ; epilepsy
Sažetak
AIMS To investigate the impact of glucuronidation enzyme (UGT1A4*3 142T>G, UGT1A4*2 70C>A, UGT2B7‐ 161 C>T) and transporter (MDR1/ABCB1 1236C>T, ABCG2 421C>A) polymorphisms on steady‐ state disposition of lamotrigine and on the lamotrigine‐ valproate interaction. METHODS Adults with epilepsy on lamotrigine monotherapy (n=131) or lamotrigine+valproate treatment (n=74) were genotyped and steady‐state lamotrigine and valproate morning troughs were determined as a part of routine therapeutic drug monitoring. RESULTS No effect of UGT and MDR1/ABCB1 polymorphisms was observed. In the entire cohort, ABCG2 421A allele had no effect however an interaction between the variant allele and valproate was observed: a) in lamotrigine‐only patients, variant allele (vs. wild type homozygosity) was independently (adjustments: age, sex, body mass index, lamotrigine dose, other polymorphisms) associated with mildly lower lamotrigine troughs (geometric means ratio, GMR=0.76, 95%CI 0.59‐0.98), whereas in lamotrigine+valproate patients it was associated with higher troughs (GMR=1.72, 95%CI 1.14‐2.62) ; b) valproate co‐ treatment was overall associated with markedly higher troughs vs. lamotrigine monotherapy (GMR=3.49, 95%CI 2.73‐4.44), but more so in variant allele carriers (GMR=5.24, 95%CI 3.38‐ 8.15) than in wild type homozygotes (GMR=2.32, 95%CI 1.89‐2.83) ; c) variant allele effects in two treatment subsets and valproate effects in two genotype subsets differed by 2.36‐ fold (95%CI 1.39‐3.67) ; d) increase in lamotrigine troughs associated with increasing valproate troughs was greater in variant allele carriers than in wild type homozygotes, i.e., variant allele effect increased with increasing valproate troughs. CONCLUSION This study is first to indicate a potentially relevant interaction between ABCG2 421C>A polymorphism and valproate in their effects on lamotrigine disposition.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Željka Petelin Gadže
(autor)
Lana Ganoci
(autor)
Nada Božina
(autor)
Vladimir Trkulja
(autor)
Mila Lovrić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE